Ethylene oxide (EtO) sterilization remains one of the most widely used methods for terminal sterilization of single-use medical devices — particularly those with complex geometry, multiple materials, electronics, or optical components that cannot withstand the temperatures of steam autoclave or the radiation doses of gamma sterilization. The process exposes packaged devices to ethylene oxide gas, typically at 30°C to 60°C and relative humidity of 40 to 80 percent, for a cycle time of several hours, followed by an extended aeration period to remove residual EtO and its reaction byproducts. For device engineers concerned with adhesive bond integrity, EtO sterilization presents a different set of concerns than heat-based methods: the primary effects are chemical sorption and potential chemical reactivity, not thermal degradation.
How EtO Interacts with Epoxy Adhesives
Ethylene oxide is a small, reactive molecule (MW 44 g/mol) with significant affinity for organic polymer matrices. At the temperature and humidity conditions of EtO sterilization, EtO diffuses into the epoxy adhesive network, absorbing into the free volume of the cured polymer. The rate of absorption depends on the temperature, the EtO concentration, and the diffusion characteristics of the specific adhesive formulation.
EtO in the absorbed state within the cured epoxy does not typically react with the fully crosslinked epoxy backbone at the concentrations and temperatures of sterilization. The concern is not chemical degradation of the adhesive network but rather two secondary effects: residual EtO content in the adhesive after aeration, and EtO reaction with specific functional groups present in the cured adhesive.
Residual EtO and its hydrolysis products — ethylene glycol and ethylene chlorohydrin (in the presence of chloride from PVC or cleaning solutions) — are the regulated species in EtO-sterilized devices. ISO 10993-7 establishes maximum allowable residual levels: for general medical devices, 4 mg of EtO per device and 9 mg of ethylene chlorohydrin per device as 24-hour acute exposure limits, with lower limits for specific contact categories and for chronic exposure scenarios.
The adhesive contributes to the device’s total residual burden based on its volume and its diffusion characteristics. Thicker adhesive sections, or formulations with high EtO uptake, take longer to degas to acceptable residual levels during aeration. Understanding the adhesive’s EtO sorption and desorption profile is necessary for validating that the aeration cycle achieves the required residual level.
Effect on Mechanical Bond Properties
The direct effect of EtO sterilization on the mechanical properties of fully cured medical-grade epoxy bonds is generally modest. At 40°C to 60°C — the sterilization temperature range — the adhesive is well below its Tg (which for medical-grade formulations is 120°C or above), so it remains in the glassy state throughout the cycle. Thermal softening is not a concern at EtO process temperatures.
Short-term moisture absorption during the humidified EtO cycle plasticizes the adhesive slightly — reduced modulus and slightly reduced tensile strength — but this effect is temporary and reverses during aeration as moisture desorbs. For adhesive joints where the substrates are moisture-sensitive (some polymer substrates absorb moisture and soften their surface), the moisture exposure of the EtO cycle may affect the adhesive-substrate interface more than the adhesive bulk.
EtO reaction with residual amine hardener in the cured adhesive can occur if the adhesive is under-cured. Amines react readily with EtO — this is the basis of EtO antimicrobial action — and if residual unreacted amine is present in the adhesive network, EtO reacts with it during sterilization, creating new chemical species in the adhesive. These reaction products may affect the adhesive mechanical properties and contribute to the residual EtO-related chemistry measurement. Fully cured adhesive with minimal residual amine hardener minimizes this reaction.
For guidance on EtO sorption data and mechanical property retention after EtO sterilization for specific formulations, Email Us — Incure can provide test data to support EtO sterilization validation.
Aeration Validation and Residual Testing
Sterilization validation under ISO 11135 (for EtO sterilization) and ISO 10993-7 (for residuals) requires demonstrating that the aeration process reduces EtO and related residuals below the maximum allowable limits before the device is released for distribution.
The validation approach involves: characterization of the EtO residual in the device immediately after sterilization (before aeration begins), measurement of residual levels at multiple time points during aeration, and confirmation that residuals are below the acceptance limit after the specified aeration time. The aeration conditions (temperature, airflow, humidity) and duration are validated for the specific device configuration — product density, packaging, and material composition all affect residual desorption rates.
For devices with significant adhesive volume — potted electronics, fully encapsulated assemblies, thick bondlines — the adhesive contribution to total residual must be characterized as part of the aeration validation. If the adhesive is the primary EtO reservoir in the device, the aeration time may need to be extended beyond what would be sufficient for a device without the adhesive component.
Accelerated aeration — aeration at elevated temperature (typically 50°C to 60°C) rather than ambient — reduces the time required to reach the residual acceptance limit by increasing the diffusion rate of EtO out of the adhesive and other device materials. Validation of an accelerated aeration cycle requires demonstrating equivalence to the unaccelerated result through testing.
Packaging and Product Geometry Considerations
The configuration of adhesive-bonded components within the device packaging affects EtO penetration and residual desorption during sterilization. EtO must reach all bonded interfaces during sterilization to ensure complete sterility; the packaging must allow gas exchange. For devices with sealed housings where the adhesive bonds create a sealed internal space, EtO may not penetrate the sealed cavity, and sterilization within the sealed space cannot be ensured.
For this reason, EtO sterilization is typically validated for the accessible, external surfaces of the device — the portions that contact the patient and the sterile field — rather than for the interior of hermetically sealed assemblies. Adhesive bonds that form the seal of a hermetic housing are not EtO-sterilized on their internal surfaces; sterility of the internal space is ensured by other means (clean assembly in controlled environments, filtered inert gas filling).
The bioburden reduction validated by EtO sterilization applies to the surfaces the gas can access. Device manufacturers must design the packaging and product configuration to allow adequate EtO exposure of all surfaces requiring sterility, and validate that the configuration achieves this.
Contact Our Team to discuss EtO sterilization compatibility, residual sorption characterization, and aeration validation support for medical-grade epoxy adhesive in your EtO-sterilized device application.
Visit www.incurelab.com for more information.